Within the framework of the Vietnam – Japan Public-Private Forum on Economic and Science-Technology Cooperation under the theme “Co-Creating Technologies, Shaping Future Value Chains”, CM Plus and the Mescells | MSC Specialised Healthcare System for Regenerative Medicine and Cell Therapy (Vietnam) (“Mescells”), represented by its member company MSC Vietnam Technology Investment and Development Joint Stock Company, have signed a Memorandum of Understanding (MOU), marking a new step in the cooperation between the two enterprises in the field of regenerative medicine, particularly the standardisation of cell manufacturing facilities (Cell Processing Center – CPC) in accordance with standards and requirements applied in Japan.
The forum was held on 9 November 2026 at The New Otani, Tokyo. The event was jointly organized by Vietnam’s Ministry of Finance, Ministry of Science and Technology, and Embassy of Vietnam in Japan, with the participation of Japan’s Ministry of Economy, Trade and Industry (METI), Ministry of Education, Culture, Sports, Science and Technology (MEXT), Ministry of Internal Affairs and Communications (MIC), and Japan External Trade Organization (JETRO) as co-organisers.
With the attendance of approximately 800–1,000 delegates, the forum gathered senior leaders of the two countries, representatives of ministries, sectors, economic and trade organisations, as well as numerous leading cooperations and enterprises from Vietnam and Japan.
Cooperation Scope
Under the MOU, both parties establish a cooperative framework toward CM Plus providing professional consulting services to Mescells in the process of standardising and registering for accreditation of the cell processing facility in Hanoi according to Japanese standards and requirements applicable to Cell Processing Centers (CPC). The cooperation aims for Mescells’ cell manufacturing facility to achieve compliance with the standards set by the regulatory authority – Japan’s Ministry of Health, Labour and Welfare (MHLW).
Through this cooperation, Mescells has the opportunity to access expertise, quality management methodologies, and technical requirements applied in Japan in the field of cell processing and manufacturing. This serves as the foundation for the enterprise to step-by-step enhance managerial capabilities, refine quality systems, and develop infrastructure dedicated to the field of regenerative medicine in Vietnam.
Promoting Vietnam – Japan Science and Technology Cooperation
In the context where Vietnam and Japan continue to expand economic, scientific, and technological cooperation, the collaboration between CM Plus and Mescells demonstrates the professional connection between enterprises of the two countries in a high-tech, knowledge-intensive sector.
Through combining the consulting and quality management experience of the Japanese enterprise with the strategic development direction of regenerative medicine in Vietnam, both sides aim to enhance cell processing facility standardisation capabilities, foster professional exchange, and establish the cornerstone for long-term cooperative activities.
CM Plus expects that the cooperative relationship with Mescells will contribute to expanding business linkage activities between Japan and Vietnam in the life sciences and regenerative medicine sectors while contributing to the development of quality management and professional capabilities in this field in Vietnam.
Mescells | MSC Specialized Healthcare System for Regenerative Medicine and Cell Therapy (Vietnam)
Mescells|MSC is a healthcare system specialising in research, training, and production applications of regenerative medicine and cell therapy. MSC Vietnam Technology Investment and Development Joint Stock Company, the signatory of the MOU, is a member company of the system.
Mescells Research Institute of Applied Cell Technology is one of the private institutions in Vietnam licensed by the Ministry of Science and Technology for research on cell technology and cell therapies in regenerative medicine.
In parallel with research activities, Mescells Institute is also licensed by the Administration of Science, Technology and Training (Ministry of Health) to provide training for physicians and healthcare personnel on stem cell technology, contributing to enhancing professional competency in regenerative medicine in Vietnam.
In addition, Mescells Tissue Bank is one of the first private tissue banks in Vietnam licensed to operate by the Ministry of Health, functioning in receiving, preserving, storing, and transporting adipose tissue and umbilical cord tissue.
With a closed-loop and specialised ecosystem in cell technology, Mescells|MSC aims to become a leading institution in Vietnam in research – application – training, while supplying standardised cell products for research, clinical trials, and clinical applications.
Website: https://mescells.com/en/